Learn More
Discovering the unintended 'off-targets' that predict adverse drug reactions is daunting by empirical methods alone. Drugs can act on several protein targets, some of which can be unrelated by conventional molecular metrics, and hundreds of proteins have been implicated in side effects. Here we use a computational strategy to predict the activity of 656(More)
We introduce SARANEA, an open-source Java application for interactive exploration of structure-activity relationship (SAR) and structure-selectivity relationship (SSR) information in compound sets of any source. SARANEA integrates various SAR and SSR analysis functions and utilizes a network-like similarity graph data structure for visualization. The(More)
Virtual screening using bioactivity profiles has become an integral part of currently applied hit finding methods in pharmaceutical industry. However, a significant drawback of this approach is that it is only applicable to compounds that have been biologically tested in the past and have sufficient activity annotations for meaningful profile comparisons.(More)
For chemical genetics and chemical biology, an important task is the identification of small molecules that are selective against individual targets and can be used as molecular probes for specific biological functions. To aid in the development of computational methods for selectivity analysis, molecular benchmark systems have been developed that capture(More)
To incorporate protein-ligand interaction information into conventional two-dimensional (2D) fingerprint searching, interacting fragments of active compounds were extracted from X-ray structures of protein-ligand complexes and encoded as structural key-type fingerprints. Similarity search calculations with fingerprints derived from interacting fragments(More)
Close structural relationships between approved drugs and bioactive compounds were systematically assessed using matched molecular pairs. For structural analogs of drugs, target information was assembled from ChEMBL and compared to drug targets reported in DrugBank. For many drugs, multiple analogs were identified that were active against different targets.(More)
Molecular Formal Concept Analysis (MolFCA), an adaptation of formal concept analysis from information theory, is introduced for the systematic comparison of the selectivity of a compound against multiple targets and the extraction of compounds with complex selectivity profiles from biologically annotated databases. In MolFCA, multiple selectivity queries(More)
From a medicinal chemistry point of view, one of the primary goals of high throughput screening (HTS) hit list assessment is the identification of chemotypes with an informative structure-activity relationship (SAR). Such chemotypes may enable optimization of the primary potency, as well as selectivity and phamacokinetic properties. A common way to(More)
For the computational exploration of structure-selectivity relationships, a compound selectivity system consisting of 243 antagonists of ionotropic glutamate ligand-gated ion channels was designed. Selected antagonists were organized in nine different selectivity sets. In systematic selectivity search calculations utilizing these data sets, structural(More)
We report the development and application of the Topological Fragment Index (ToFI), a measure for the complexity of the topological environment of defined molecular fragments in active compounds. On the basis of ToFI calculations, RECAP fragments are organized in dependency hierarchies that capture fragment co-occurrence and facilitate the identification of(More)